Top Markets
Coin of the day
Phoenix Biotech Acquisition Corp. Phoenix Biotech Acquisition Corp.

Phoenix Biotech Acquisition Corp.

PBAX
Rangering i aksjer #15372
Phoenix Biotech Acquisition Corp. currently lacks substantial business... Phoenix Biotech Acquisition Corp. currently lacks substantial business operations. The company's primary objective is to complete a strategic business combination, such as a merger, asset acquisition, share exchange, or other form of reorganization, with one or more suitable enterprises. Its focus is on identifying and integrating with a firm engaged in the healthcare or healthcare-related industries within the United States or Europe. This entity was established in 2021 and maintains its headquarters in Oakland, California.
Aksjekurs
$5.85
Sist synkronisert: 2024-02-14
Markedsverdi
$356.42M
Endring (1 dag)
4.65%
Endring (1 år)
0.00%
Land
US
Handel Phoenix Biotech Acquisition Corp. (PBAX)
Pris PBAX pris med markedsverdi på B
Phoenix Biotech Acquisition Corp. Phoenix Biotech Acquisition Corp.
PBAX
$5.85
Markedsverdi av Phoenix Biotech Acquisition Corp.(PBAX)
Markedsverdi: $356.42M
Per September 2026 har Phoenix Biotech Acquisition Corp. en markedsverdi på $356.42M. Dette gjør Phoenix Biotech Acquisition Corp. til det 15372nd mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Phoenix Biotech Acquisition Corp. fra 2021 til 2026
PBAX sammenlignet med topp 5 mest populære stocks
Pris på PBAX Eiendel B Markedsverdi for B Resultater
Phoenix Biotech Acquisition Corp. Phoenix Biotech Acquisition Corp.
$87,430.81 $356.42M
$5.327T +1,494,443.74%
Phoenix Biotech Acquisition Corp. Phoenix Biotech Acquisition Corp.
$76,238.08 $356.42M
$4.645T +1,303,115.11%
Phoenix Biotech Acquisition Corp. Phoenix Biotech Acquisition Corp.
$66,806.70 $356.42M
$4.070T +1,141,894.83%
Phoenix Biotech Acquisition Corp. Phoenix Biotech Acquisition Corp.
$62,117.72 $356.42M
$3.785T +1,061,741.42%
Phoenix Biotech Acquisition Corp. Phoenix Biotech Acquisition Corp.
$45,795.32 $356.42M
$2.790T +782,726.06%